Last update :
14/02/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antihistamine (H2)   Ranitidine hydrochloride  
injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Acloral Mexico
Epadoren Greece, Malaysia
Lumaren Greece
Ptinolin Greece
Ranigast Poland
Ranitab Ecuador, Turkey
Ranitic Germany
Ranitidin Germany
Rantag Saudi Arabia, United Arab Emirates
Ulcuran Turkey
Ulsal Austria
Zantac Austria, Belgium, Canada, Colombia, Denmark, Ecuador, Egypt, Greece, Iceland, Malaysia, Netherlands, New Zealand, Poland, Portugal, Saudi Arabia, Spain, United Arab Emirates, United States of America, Venezuela
Zydac Saudi Arabia, United Arab Emirates
Stability in solutions   injection   Stability in solutions : Ranitidine hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for injection + antibacterial 2,5 mg/ml 4°C Protect from light
91 Day
46
Level of evidence C
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 mg/ml 20°C-25°C Light
7 Day
213
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 & 1 mg/ml -30°C Protect from light
30 Day
358
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 & 1 & 2 mg/ml -20°C Protect from light
60 Day
78
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 & 1 & 2 mg/ml 25°C Light
7 Day
78
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 & 1 & 2 mg/ml 4°C Protect from light
30 Day
78
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 >> 2 mg/ml 20°C-25°C Light
28 Day
213
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 25°C Not specified
15 Day
693
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 4°C Protect from light
10 Day
358
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 4°C Protect from light
92 Day
689
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 5°C Protect from light
63 Day
693
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 2 mg/ml -30°C Protect from light
100 Day
358
Level of evidence A
Polyvinyl chloride Glucose 10% 0,05 mg/ml 20°C-25°C Light
2 Day
213
Level of evidence B
Polyvinyl chloride Glucose 10% 0,5 & 1 & 2 mg/ml -20°C Protect from light
60 Day
78
Level of evidence A
Polyvinyl chloride Glucose 10% 0,5 & 1 & 2 mg/ml 25°C Light
7 Day
78
Level of evidence A
Polyvinyl chloride Glucose 10% 0,5 & 1 & 2 mg/ml 4°C Protect from light
30 Day
78
Level of evidence A
Polyethylene NaCl 0,9% or Glucose 5% 0,25 mg/ml 22°C Protect from light
24 Hour
1067
Level of evidence C
Polyethylene NaCl 0,9% or Glucose 5% 0,25 mg/ml 4°C Protect from light
24 Hour
1067
Level of evidence C
Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 25°C With or without light
91 Day
4131
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 5°C Protect from light
91 Day
4131
Level of evidence A
Polypropylen Syringe Water for injection + antibacterial 2,5 mg/ml 22°C Not specified
72 Hour
46
Level of evidence C
Polypropylen Syringe Water for injection + antibacterial 2,5 mg/ml 4°C Protect from light
91 Day
46
Level of evidence C
  Mentions Légales